Naseptin is NOT appropriate for treating impetigo
Naseptin should not be used for impetigo because it is a nasal decongestant, not an antibiotic preparation for skin infections. There appears to be confusion with the term "Naseptin" - the FDA drug label provided 1 describes a nasal decongestant for congestion, not the neomycin-containing antibiotic preparation you may be thinking of.
What You Should Use Instead
For impetigo treatment, current guidelines recommend:
First-Line Topical Options
- Mupirocin or retapamulin are the recommended topical antibiotics 2
- These are as effective as oral antimicrobials for localized impetigo 2
When to Use Systemic Therapy
Switch to oral antibiotics when 2:
- Patient has numerous lesions
- Outbreak affecting multiple people (to decrease transmission)
- Deeper infection (ecthyma) is present
Oral Antibiotic Choices
Since most impetigo involves S. aureus and/or β-hemolytic streptococci 2, 3:
- Oral penicillinase-resistant penicillin or first-generation cephalosporins (most staphylococcal isolates are methicillin-susceptible) 2
- For penicillin allergy or MRSA: doxycycline, clindamycin, or trimethoprim-sulfamethoxazole 2
- If streptococci alone: penicillin is drug of choice 2
Special Consideration for MRSA
Empiric therapy for community-acquired MRSA should be considered for 3:
- Patients at risk for CA-MRSA
- Those not responding to first-line therapy
Important Caveats
The triple antibiotic ointment (neomycin-bacitracin-polymyxin B) mentioned in some research 4, 5, 6, 7 is different from Naseptin and is primarily for minor wound infection prevention, not established impetigo. While this combination shows activity against relevant pathogens 6, it is not guideline-recommended for impetigo treatment where mupirocin has become the topical standard 2.
Impetigo is highly contagious, particularly in children 3, so prompt appropriate antibiotic therapy is essential for both treatment and transmission control.